Conversio Health Recalls Albuterol and Ipratropium Inhalation Vials
Conversio Health is recalling Albuterol and Ipratropium inhalation vials nationwide due to a lack of processing controls.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity recall involving potential but unreported adverse health consequences.
Plain-English summary
Integrated Health Concepts Inc. dba Conversio Health is recalling Albuterol 3.75mg / Ipratropium 0.75mg, 3ML Vials, For Inhalation Only. The recall is being conducted because of a lack of processing controls. The affected products were distributed nationwide in the U.S. and include all lots.
The source text does not specify the exact nature of the processing control failure or report any specific illnesses or injuries associated with the use of these products. The recall is classified as Class II by the FDA, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have these products should stop using them and contact the recalling firm for further instructions or a refund. The source text does not provide specific contact information for the recalling firm.
The recalled product
- Product
- Albuterol 3.75mg / Ipratropium 0.75mg, 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.
- Category
- Drug — Inhalation Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Integrated Health Concepts Inc. dba Conversio Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Integrated Health Concepts Inc. dba Conversio Health
See all →- ModerateConversio Health Recalls Budesonide Inhalation Vials Due to Processing Control Issues
FDA (Drugs) · 2019-11-27
- ModerateConversio Health Recalls Albuterol and Ipratropium Vials Due to Processing Controls
FDA (Drugs) · 2019-11-27
- ModerateConversio Health Recalls Albuterol and Ipratropium Vials Due to Processing Controls
FDA (Drugs) · 2019-11-27
- ModerateConversio Health Recalls Albuterol and Ipratropium Inhalation Vials
FDA (Drugs) · 2019-11-27
- ModerateConversio Health Recalls Albuterol, Ipratropium, and Budesonide Inhalation Vials
FDA (Drugs) · 2019-11-27
Same hazard · processing control deficiency
See all →- ModerateDoxycycline oral suspension recalled for insanitary manufacturing conditions
FDA (Drugs) · 2022-07-13
- ModerateMasterPharm Recalls Testosterone/Anastrozole Pellets Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- SevereRedline Pharmacy Recalls Morphine Sulfate Due to Processing Control Deficiencies
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Ertapenem Injectable Due to Processing Control Issues
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Vancomycin Injectable Due to Processing Control Deficiencies
FDA (Drugs) · 2020-03-18